SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-286790
Filing Date
2023-12-01
Accepted
2023-12-01 08:01:03
Documents
14
Period of Report
2023-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d559453d8k.htm   iXBRL 8-K 30774
2 EX-99.1 d559453dex991.htm EX-99.1 11451
6 GRAPHIC g559453g1201032651915.jpg GRAPHIC 4921
  Complete submission text file 0001193125-23-286790.txt   182283

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycn-20231130.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20231130_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20231130_pre.xml EX-101.PRE 11711
8 EXTRACTED XBRL INSTANCE DOCUMENT d559453d8k_htm.xml XML 3459
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 231457559
SIC: 2834 Pharmaceutical Preparations